Skip to Content

ST-246 FDA Approval Status

FDA Approved: No
Brand name: ST-246
Company: SIGA Technologies, Inc.
Treatment for: Exposure to Smallpox Virus

ST-246 is an orally active, smallpox antiviral in development to treat individuals exposed to the smallpox virus in the event of an outbreak.

Development Timeline for ST-246

DateArticle
Apr  4, 2008SIGA Initiates Manufacture of ST-246 NDA Registration Batches
Mar 24, 2008SIGA Files Application Supporting Emergency Use Approval for ST-246

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.